Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.
The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.
Estepp claims she was never given a reason for her firing. Her attorney, Sarah Prescott, filed a lawsuit against Huntington Bank on Monday, alleging that the grieving mother — who was trying to be ...
This study presents a useful finding that targeting amino acid metabolism can overcome Trastuzumab resistance in HER2+ breast cancer. The evidence supporting the claims of the authors is solid and the ...
Breast cancer symptoms can vary, and some may not be immediately apparent - one less well-known sign to watch out for involves checking the skin on and around your breasts ...